← Eichor
Study identifier: NCT02211365 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Registro Campania Salute Network on Hypertension

Condition: Hypertension; Heart Disease, Hypertensive  ·  Sponsor: Federico II University

PhaseN/A
Planned participants10000
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersNo

About this study

The Registro Campania Salute Network (RCSN) is a prospective registry aimed at improving the management of essential hypertension by integrating the activity of general practitioners (GPs) with that of the hypertension specialist. It involves selected GPs homogeneously allocated in the regional area, and the Hypertension Clinic of the Federico II University in Naples, which served as co-ordinating centre. Through the RCSN system it is possible to store clinical data detected at each visit between the peripheral units and the co-ordinating centre and to support scientific analysis of the dataset.

This description comes directly from the study's public registry record.

Talk to the study team

Bruno Trimarco, MD  ·  +390817462250  ·  trimarco@unina.it

eugenio stabile, MD  ·  +393316776019  ·  eugeniostabile@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Department od advanced biomedical sciences, Università degli studi di Napoli Federico II, Via sergio Pansini 5Naples, Napoli, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02211365